|
CKAP2L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.09152703437121E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.045420E-04 |
| Normal-vs-Stage2 |
1.065990E-01 |
| Normal-vs-Stage3 |
1.214860E-04 |
| Normal-vs-Stage4 |
1.909750E-02 |
| Stage1-vs-Stage2 |
5.250400E-01 |
| Stage1-vs-Stage3 |
1.859310E-03 |
| Stage1-vs-Stage4 |
4.551700E-02 |
| Stage2-vs-Stage3 |
5.044200E-02 |
| Stage2-vs-Stage4 |
5.143800E-02 |
| Stage3-vs-Stage4 |
6.046200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.69540001429647E-09 |
| Normal-vs-AfricanAmerican |
9.823800E-04 |
| Normal-vs-Asian |
9.670200E-02 |
| Caucasian-vs-AfricanAmerican |
7.755800E-01 |
| Caucasian-vs-Asian |
2.974200E-01 |
| AfricanAmerican-vs-Asian |
2.261200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7392000062344E-09 |
| Normal-vs-Female |
1.98304999999843E-05 |
| Male-vs-Female |
1.942400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.341600E-03 |
| Normal-vs-Extreme_Weight |
1.72038999999291E-05 |
| Normal-vs-Obese |
1.573780E-04 |
| Normal-vs-Extreme_Obese |
1.582240E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.240000E-02 |
| Normal_Weight-vs-Obese |
5.620600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.860900E-03 |
| Extreme_Weight-vs-Obese |
1.050020E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.363600E-02 |
| Obese-vs-Extreme_Obese |
8.157500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.310230E-02 |
| Normal-vs-Age(41-60Yrs) |
2.42640000314154E-08 |
| Normal-vs-Age(61-80Yrs) |
4.19540000000662E-05 |
| Normal-vs-Age(81-100Yrs) |
2.471800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.313800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.365700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.421700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.568200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.466400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.248800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.01470000002379E-06 |
| Normal-VS-Type2 PRCC |
1.58083999999281E-05 |
| Normal-VS-KIRP CIMP |
3.122400E-03 |
| Normal-VS-Unclassified PRCC |
4.25860000000666E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.876400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.722400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.272310E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.177520E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.176600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.583500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.789000E-04 |
| Normal-vs-N1 |
4.4735000000018E-05 |
| Normal-vs-N2 |
1.144160E-01 |
| N0-vs-N1 |
1.215430E-03 |
| N0-vs-N2 |
1.507010E-01 |
| N1-vs-N2 |
4.381400E-01 |
|
|
